The burgeoning landscape of emerging treatments for body management has seen the rise of both retatrutide and tirzepatide, both dual approach agonists targeting the GLP-1 and GIP receptors. While sharing a comparable https://owainpjrj267990.sasugawiki.com/7557560/retatrutide_vs_tirzepatide_a_comparative_analysis